MIRA INFORM REPORT

 

 

Report Date :

08.07.2011

 

IDENTIFICATION DETAILS

 

Name :

SREEPATHI LAB PRIVATE LIMITED

 

 

Registered Office :

103, Tirumala Gardens, Ranga Raju Lane, Road No.1, Banjara Hill, Hyderabad- 500034, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

04.06.2004

 

 

Com. Reg. No.:

01-043403

 

 

Capital Investment/ Paid-up Capital:

Rs. 53.500 Millions

 

 

CIN No.:

[Company Identification No.]

U24239AP2004PTC043403

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDS10413E

 

 

Legal Form :

Private limited liability company

 

 

Line of Business :

Manufacturers and Exporters of Pharmaceutical active Ingredients, Drug Intermediates and Fine Chemicals.

 

 

No. of Employees:

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (27)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Maximum Credit Limit :

USD 310000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. Profitability of the company appears to be low. However, trade relations are reported as fair. Business is active. Payments are reported to be slow.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

LOCATIONS

 

Registered Office :

103, Tirumala Gardens, Ranga Raju Lane, Road No.1, Banjara Hill, Hyderabad- 500034, Andhra Pradesh, India

Tel. No.:

91-40-23351381

Fax No.:

91-40-40144663

E-Mail :

purchase@sreepathilab.com

sreepathilab@vsnl.net

Website :

www.sreepathilab.com

 

 

Corporate Office:

Flat -5B, 5th Floor, 6-3-347/20/3A, Divya Sai Shakti Apartments, Dwarkapuri Colony, Punjagutta, Hyderabad- 500082, Andhra Pradesh, India

Tel No.:

91-40-23351381 / 23351382

Fax No.:

91-40- 40144663

E-Mail :

anup@sreepathilab.com

purchase@sreepathilab.com

ashanup@vsnl.net

sreepathilab@vsnl.net

 

 

Factory  :

Survey No. 26/27, National Highway No. 9, Gundrampallyn Village, Chityal Mandal, Nalgonda District-508114, India

 

 

DIRECTORS

 

As on 30.09.2010

 

Name :

Mr. Anup Agarwal

Designation :

Managing Director

Address :

Flat No.103, Tirumala Gardens, Ranga Rajulane Road No.1, Banjara Hill, Hyderabad- 500034, Andhra Pradesh, India

Date of Birth/Age :

01.08.1967

Date of Appointment :

15.12.2006

DIN No.:

00166577

Other Directorship :

Yutika Holding Private Limited

CIN : U67120AP2005PTC047532

 

 

Name :

Mr. Satyanarayana Venkata Sakhamuri

Designation :

Director

Address :

495 RT Sanjeev Reddy Nagar, Hyderabad- 500038, Andhra Pradesh, India

Date of Birth/Age :

01.09.1965

Date of Appointment :

03.10.2006

DIN No.:

00841032

 

 

Name :

Mr. Gajanand Gupta

Designation :

Director

Address :

5-9-22, 108 1st Floor, Adarsh Nagar, Hyderabad-500063, Andhra Pradesh, India

Date of Birth/Age :

04.09.1951

Date of Appointment :

03.10.2006

DIN No.:

01643269

 

 

Name :

Mr. Asha Agarwal

Designation :

Director

Address :

Flat No.103, Tirumala Gardens, Ranga Rajulane Road No.1, Banjara Hill, Hyderabad- 500034, Andhra Pradesh, India

Date of Cessation :

06.10.2006

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2010

 

Names of Shareholders

 

No. of Shares

Anand Gupta

 

110000

Anup Agarwal

 

305500

Asha Agarwal

 

708500

RAmakant Panda

 

25000

Atika Gupta

 

30000

C Vijaya Mohan Reddy

 

170000

Vivek Gupta

 

30000

Gajanand Gupta

 

265000

Gajanand Gupta (HUF)

 

80000

J Manjula Devi

 

81000

Kailash Store Private Limited, Kolkata, India

 

100000

K C. Agarwal

 

5000

M Muthuvaradhan

 

32000

M V Nandiunl

 

83000

M V Raman

 

110000

Rajdeep Marketing Private Limited, Kolkata, India

 

180000

Rose Commodities

 

100000

Sangeeta Gupta

 

35000

S Anita

 

900500

Sanjay Agarwal

 

77000

Sanjay Gupta

 

35000

Anand Ghupta

 

50000

Shashikala Gupta

 

40000

S V Satyanarayana

 

1098500

S V R V Prasad

 

225000

Devender Kumar Gupta

 

25000

Vijetha Gupta

 

40000

Vikram Gupta

 

50000

Yuthika Impex Private Limited, Andhra Pradesh, India

 

359000

Total

 

5350000

 

Equity Share Breakup (Percentage of Total Equity)

As On (30.09.2010)

 

Category

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

Total

 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturers and Exporters of Pharmaceutical active Ingredients, Drug Intermediates and Fine Chemicals.

 

 

Products :

Product Description

ITC Code

Slidenafil Citrate

29420090

Quinapyramine Salts

29392120

 

  • Quinapyramine Sulphate BVET C
  • Quinapyramine Chloride BVET C
  • Sildenafi Citrate
  • Ciprofloxacin HCL/ Base
  • Enrofloxacin
  • Ofloxacin
  • Gibenclamide
  • Tenoxicam
  • Phenprobamate

 

 

 

PRODUCTION STATUS AS ON (31.03.2010)

 

Particulars

Unit

 

Installed Capacity

Actual Production

Sidenfil Citrate

TPA

 

24

--

Ciprofloxacin

TPA

 

180

0.025

N-methyl Piperazine

TPA

 

120

8.400

Quinapyramine Salt

TPA

 

4

2.671

Ethoxy Benszonic Acid

TPA

 

72

58.237

Acetonitrile

TPA

 

--

72.160

Others

TPA

 

--

785.262

Ciprofloxacin HCL

TPA

 

--

91.480

 

GENERAL INFORMATION

 

Bankers :

  • State Bank of India

Industrial Finance Branch, 1st Floor, Navbharat Chambers, Raj Bhavan Road, Somajiguda, Hyderabad- 500082, Andhra Pradesh, India

 

 

Facilities:

Secured Loans

31.03.2010

Rs. in Millions

31.03.2009

Rs. in Millions

From State Bank of India

 

 

Term Loans

85.973

97.020

Interest outstanding on Term Loan

0.913

0.000

Working Capital

49.809

49.609

Hire Purchase Loans

0.637

0.637

Total

137.332

147.266

 

 

 

Unsecured Loans

31.03.2010

Rs. in Millions

31.03.2009

Rs. in Millions

From Directors

7.117

0.000

From Others

10.800

0.000

From Companies

3.500

0.000

Total

21.417

0.000

 

Banking Relations :

--

 

 

Auditors :

 

Name :

CKS Associates

Chartered Accountant

Address :

87 Road No.3, Gagan Mahal Colony, Hyderabad- 500029, Andhra Pradesh, India

Pan No.:

AABFC2043A

 


 

CAPITAL STRUCTURE

 

As on 31.03.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

6000000

Equity Shares

Rs.10/- Each

Rs. 60.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

5350000

Equity Shares

Rs.10/- Each

Rs. 53.500 Millions

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

53.500

53.500

30.000

2] Share Application Money

13.558

7.734

20.436

3] Reserves & Surplus

10.697

10.383

5.368

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

77.755

71.617

55.804

LOAN FUNDS

 

 

 

1] Secured Loans

137.332

147.266

97.423

2] Unsecured Loans

21.417

0.000

5.643

TOTAL BORROWING

158.749

147.266

103.066

DEFERRED TAX LIABILITIES

4.404

0.743

0.782

 

 

 

 

TOTAL

240.908

219.626

159.652

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

156.126

126.260

23.176

Capital work-in-progress

7.467

30.793

106.322

 

 

 

 

INVESTMENT

0.539

0.539

0.539

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

81.126

39.706

18.713

 

Sundry Debtors

23.027

39.969

25.756

 

Cash & Bank Balances

6.532

11.152

1.157

 

Other Current Assets

5.655

0.770

0.164

 

Loans & Advances

33.249

38.831

21.923

Total Current Assets

149.589

130.428

67.713

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

68.749

71.518

37.439

 

Other Current Liabilities

13.494

2.373

0.349

 

Provisions

0.760

0.593

0.310

Total Current Liabilities

83.003

74.484

38.098

Net Current Assets

66.586

55.944

29.615

 

 

 

 

MISCELLANEOUS EXPENSES

10.190

6.090

0.000

 

 

 

 

TOTAL

240.908

219.626

159.652

 

 


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

 

 

Income

352.148

277.143

98.836

 

 

Other Income

9.354

0.917

0.142

 

 

TOTAL                                     (A)

361.502

278.060

98.978

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Material

314.749

249.322

77.391

 

 

Payments and benefits to Employees

8.353

8.416

2.010

 

 

Manufacturing, Selling and Administrative Expenses

33.349

24.584

13.726

 

 

Product Development Expenditure Written off

1.353

0.676

0.000

 

 

Adjustment for Stocks

[28.965]

[30.912]

0.451

 

 

Prior Period Expenditure

0.405

0.009

0.057

 

 

TOTAL                                     (B)

329.244

252.095

93.635

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

32.258

25.965

5.343

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

21.707

16.335

1.401

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

10.551

9.630

3.942

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

6.507

4.351

0.736

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

4.044

5.279

3.206

 

 

 

 

 

Less

TAX                                                                  (H)

3.729

0.264

1.070

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

0.315

5.015

2.136

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

10.383

5.368

3.232

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

10.698

10.383

5.368

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

 

 

 

Basic

0.06

1.37

1.02

 

Diluted

0.05

1.13

1.02

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

0.09

1.80

2.16

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

1.15

1.90

3.24

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

1.32

2.06

3.53

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.05

0.07

0.06

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

3.11

3.10

0.68

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.80

1.75

1.78

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Operations during the year:

 

Commercial production of the expanded production capacity from 24 MTs to 72 MTS of 2 Ethoxy Benzoic Aicd at Gundrampally, Nalgonda District, Andhra Pradesh has commenced with effect from September 30, 2010

 

Bankers Charges Report as per Registry

 

This form is for

Modification of charge

Charge identification number of the modified 

10054062

Corporate identity number of the company

SREEPATHI LAB PRIVATE LIMITED

Name of the company

SREEPATHI LAB PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

103, Tirumala Gardens, Ranga Rajulane Road No.1, Banjara Hill, Hyderabad- 500034, Andhra Pradesh, India

Type of charge

Immovable property

Book Debts

Movable Property

Other

Particular of charge holder

  • State Bank of India

Industrial Finance Branch, Raj Bhavan Road, Somajiguda, Hyderabad- 500082, Andhra Pradesh, India

 

E-Mail: sa.9103@sbi.co.in

Nature of description of the instrument creating or modifying the charge

Supplemental agreement of loan for increase in the overall limit – Form C 1 A

Supplemental Agreement  of hypothecation of goods and assets for increase in the overall limit – Form C 2 A

Supplemental Deed of Guarantee for increase in overall limit – Form C 5

Letter regarding the grant of individual limits within the overall limits – Form C 5

Memorandum for recording extension of mortgage by deposit of title deeds.

Date of instrument Creating the charge

20.03.2009

Amount secured by the charge

Rs.236.000 millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest

Cash credit hypothecation – 2.50% above SBAR effective rate 14.75%

Term Loan-I-0.5% over SBAR from 30.03.2009 subject to reset after two years from that date

Term Loan –II-2% above SBAR

 

Terms of Repayment

Cash credit hypothecation – Repayable on demand

Term Loan- I and II- Repayable commences from September 2009

Term Loan I- Repayable in 17 quarterly installments

Term Loan II- Repayable in 13 quarterly installments

 

Margin

Cash credit

RM, SIP and FG- 25%

Receivables- 40% (cover period 100 days)

Letter of credit – 15%

BG-20%

 

Extent and Operation of the charge

CC: Exclusive charge on current assets of the company.

 

Extension of charge on fixed assets and EM of immovable Property (company’s land) land of Acres 12.09 guntas vide sale deed number 6090/ 2006 and the property belong to the director and individual.

Short particulars of the property charged

Charge on the entire stock, book debts and other current assets of the company both present and future. Extension of charge on the fixed assets of the company and EM of the land belonging to the company.

Date of latest modification prior to the present modification

31.03.2008

Particulars of the present modification 

Total limits have been enhanced from Rs.156.000 millions to Rs.236.000 millions with increase in the fund based working capital limits from Rs.30.000 millions to Rs.80.000 millions and increase in the Non Fund based working capital limits from Rs.30.000 millions to Rs.60.000 millions. Other terms and conditions remain the same except change in the repayments period of the term loan.

 

Fixed Assets

 

  • Land
  • Building
  • Plant and Machinery
  • Office Equipments
  • Computer
  • Furniture and Fixture
  • Vehicles

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.42

UK Pound

1

Rs.70.95

Euro

1

Rs.63.63

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

2

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

27

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.